Last updated on

Journal of Clinical Oncology
Research Hotspot & Journal Scope - response


Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.502
HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial.

Otto Metzger Filho · Giuseppe Viale · Lorenzo Trippa · Tianyu Li · Denise A. Yardley · Ingrid A. Mayer · Vandana G. Abramson · Carlos L. Arteaga · Laura Spring · Adrienne G. Waks · Michalina Janiszewska · Eileen Wrabel · Michelle Demeo · Aditya Bardia · Tari A. King · Kornelia Polyak · Eric P. Winer · Ian E. Krop ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.9020
Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial.

Caicun Zhou · Fumio Imamura · Ying Cheng · Isamu Okamoto · Byoung Chul Cho · Meng Chih Lin · Margarita Majem · Oliver Gautschi · Jhanelle E. Gray · Michael Boyer · Juliann Chmielecki · Ryan J. Hartmaier · Krishna Bulusu · J. Carl Barrett · Rachel Hodge · Matilde Saggese · Astrid McKeown · Suresh S. Ramalingam ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.7562
Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma.

Erin Dean · Hong Lu · Aleksandr Lazaryan · Gabriel S Krivenko · Christina A Bachmeier · Julio C. Chavez · Marco L. Davila · Farhad Khimani · Hien Liu · Javier Pinilla-Ibarz · Bijal D. Shah · Michael D. Jain · Yoganand Balagurunathan · Frederick L. Locke ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.4_SUPPL.60
Association of DNA damage response and repair genes (DDR) mutations and microsatellite instability (MSI), PD-L1 expression, tumor mutational burden (TMB) in gastroesophageal cancers.

Michael Cerniglia · Joanne Xiu · Axel F Grothey · Michael J. Pishvaian · Jimmy J. Hwang · John Marshall · Ari M. Vanderwalde · Anthony F. Shields · Heinz-Josef Lenz · Mohamed E. Salem · Philip A. Philip · Richard M. Goldberg · W. Michael Korn · Sunnie S. Kim ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.8563
BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response—Preliminary results from the SCLC cohort.

Rieke Fischer · Julie George · Andreas H. Scheel · Hans Anton Schloesser · Maria J.G.T. Vehreschild · Peter Brossart · Walburga Engel-Riedel · Frank Griesinger · Christian Grohé · Karl-Otto Kambartel · Jens Kern · Barbara Hermes · Kathrin Nachtkamp · Jens Panse · Martin Sebastian · Markus Lehmann · Rainer Wiewrodt · Reinhard Büttner · Roman K. Thomas · Juergen Wolf ·

Medicine
PDF

Highly Related Keywords from response

Research Hotspot

Journal of Clinical Oncology

Research Hotspot
Journal of Clinical Oncology Related Journals

Popular Journals